Study of three-step treatment approach reopens question of donor bone marrow transplant
Nov. 9, 2017
| by Susan Keown / Fred Hutch News Service
A new study offers a clue for solving a long-standing controversy in multiple myeloma: namely, whether a bone marrow transplant from a donor could be beneficial for patients with this disease and, if so, for which patients.
Dr. Rainer Storb's research into less toxic forms of allogeneic marrow and blood stem-cell transplantation for malignant and non-malignant blood diseases has earned him a $150,000 award from the prestigious Jacqueline Seroussi Memorial Foundation for Cancer Research in Israel.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.